Akebia Therapeutics, Inc.
Lobbying group · Jul 2025 – Sep 2026
Akebia Therapeutics, Inc. spent $1.4M lobbying the federal government (Jul 2025 – Sep 2026), mostly on health care, medicare & medicaid. It used 9 lobbyists, including people who worked for 1 members of Congress.
- Spent on lobbying
- $1.4M
- Lobbyists
- 9
- Bills lobbied
- 4
- Issues
- 2
Spending by quarter
- 2025 Q3$280K
- 2025 Q4$260K
- 2026 Q1$480K
- 2026 Q2$360K
Issues lobbied
- Health care
- Medicare & Medicaid
Bills lobbied on
- S. 11734 reports
- H.R. 21994 reports
- S. 27304 reports
- H.R. 62143 reports
Lobbying firms hired
- Akebia Therapeutics, Inc.$1.4M
- Bgr Government Affairs$220K
- The Petrizzo Group, Inc.$195K
Lobbyists who worked in Congress
- Daniel Farmer
Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for…Debbie Wasserman Schultz (D-FL)
Agencies contacted
- House Of Representatives · 20
- Senate · 20
- Centers For Medicare and Medicaid Services (Cms) · 14
- Health & Human Services, Dept of (Hhs) · 9
- Office of Management & Budget (Omb) · 2
Related
Filings
- 2026 Q2 report$60K
- 2026 Q2 report$360K
- 2026 Q2 report$60K
- 2026 Q1 report$60K
- 2026 Q1 report$480K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Akebia Therapeutics, Inc.: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/cakebiatherapeutics/akebia-therapeutics-inc (accessed 2026-10-17).